Modern Diagnostic IPO GMP signals ₹12 premium as ₹37 crore issue opens on BSE SME

Modern Diagnostic Services’ IPO shows a ₹12 grey market premium as the ₹37 crore issue opens on the BSE SME platform, indicating healthy sentiment.

positive
Recently

Modern Diagnostic IPO GMP signals ₹12 premium as ₹37 crore issue opens on BSE SME

1 min read61 words
Modern Diagnostic IPO GMP signals ₹12 premium as ₹37 crore issue opens on BSE SME
Modern Diagnostic Services’ IPO shows a ₹12 grey market premium as the ₹37 crore issue opens on the BSE SME platform, indicating healthy sentiment.
The IPO of Modern Diagnostic Services, a healthcare diagnostics company, opened on the BSE SME platform with its grey market premium (GMP) indicating a ₹12 premium per share, reflecting positive investor sentiment ahead of the listing. The ₹37 crore issue has garnered interest from retail and high net worth individuals, supported by optimism around the company’s growth prospects in diagnostic services. 
Sentinel